ATM and breast cancer: In this sub-group, age at breast cancer diagnosis was no longer a significant predictor of mutation status for ATM (OR 1.12, 95% CI 0.97–1.30) and PALB2 remained non-significant (OR 1.05, 95% CI 0.90–1.23).